Description
Dolasetron is an antiemetic that acts as an antagonist at 5-HT3 receptors. Dolasetron also exhibits analgesic activity, decreasing pain sensitivity in clinical subjects with fibromyalgia.
Product Unit Size | Cost | Quantity | Stock |
---|
Dolasetron is an antiemetic that acts as an antagonist at 5-HT3 receptors. Dolasetron also exhibits analgesic activity, decreasing pain sensitivity in clinical subjects with fibromyalgia.
Cas No. | 878143-33-0 |
---|---|
Purity | ≥98% |
Formula | C19H20N2O3 • CH4O3S • xH2O |
Formula Wt. | 420.48 |
IUPAC Name | methanesulfonic acid;[(3S,7R)-10-oxo-8-azatricyclo[5.3.1.03,8]undecan-5-yl] 1H-indole-3-carboxylate;hydrate |
Solubility | DMSO: ≥ 39 mg/mL H2O: >30 mg/mL |
Appearance | White to off white powder |
Store Temp | Ambient |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet |
Roberts SM, Bezinover DS, Janicki PK. Reappraisal of the role of dolasetron in prevention and treatment of nausea and vomiting associated with surgery or chemotherapy. Cancer Manag Res. 2012;4:67-73. PMID: 22427733.
Vergne-Salle P, Dufauret-Lombard C, Bonnet C, et al. A randomised, double-blind, placebo-controlled trial of dolasetron, a 5-hydroxytryptamine 3 receptor antagonist, in patients with fibromyalgia. Eur J Pain. 2011 May;15(5):509-14. PMID: 21036635.
Core structure of melatonin; potential PPARγ a...
Antimicrobial peptide.
Diterpene found in Taxus; potential microtubule...
Peptide fragment of VSV; LDLR agonist.
Retinoid; RARα/β/γ agonist.
5-HT1A partial agonist, SERT inhibitor.
Heterocyclic light-emitting compound, natural l...
Progesterone derivative; Cyp17A1 inhibitor.
11β-HSD1 inhibitor.
Triazole; 14-α demethylase inhibitor.
Proteasome inhibitor.
KRAS inhibitor
Hydantoin derivative; RyR antagonist, L-type Ca...
Metal ion chelator, viral DNA polymerase inhibi...
Aromatic 1,3-diketone acetylacetone derivative ...
Non-depolarizing NMJ blocker; nAChR antagonist....
Nucleoside (guanosine) analog; DNA chain termin...
Endogenous bombesin-like peptide, involved in f...
FIASMA, SERT and NET inhibitor, mAChR antagonis...